Moderna's COVID-19 Vaccine Shines In Clinical Trial
The vaccine is nearly 95% effective in preventing illness, according to an interim analysis of a clinical test involving 30,000 people.
Medical Treatments
Public Health Officials Face A Need To Market Coronavirus Vaccination
News of the Pfizer COVID-19 vaccine's effectiveness has inspired hope around containing the coronavirus. But polls show that up to two-thirds of Americans say they are unlikely to get a vaccine.
Pfizer CEO Sold Millions In Stock After Coronavirus Vaccine News, Raising Questions
Pfizer's CEO sold $5.6 million worth of stock on Monday. The company says the stock sale was made as part of a preset plan. But NPR found irregularities about when the CEO entered into that plan.
How A Minneapolis Clinic Is Narrowing Racial Gaps In Health
For five decades, NorthPoint Health & Wellness Center has confronted the ways disparities can hurt its patients' health. Community leaders say it's a model for cities facing similar struggles.
Novavax Posts Coronavirus Vaccine Contract That Government Didn't Disclose
The $1.6 billion Novavax contract is one of several Operation Warp Speed agreements issued through a third party, Advanced Technology International, and that hadn't been released.
Protecting Women Against HIV Just Got 9 Times Easier
A single injection of a drug called cabotegravir given every two months has been shown to be more effective than a daily oral dose of Truvada.
Author Details 'Living With Death' In Her 20s And Scrambling For Life-Saving Care
Katherine Standefer was uninsured and working as a hiking guide when diagnosed with a genetic heart condition. She chronicles her experience with an implanted heart device in Lightning Flowers.
FDA OKs Eli Lilly COVID-19 Drug, But Supplies Will Be Limited
Eli Lilly's monoclonal antibody will be available to people 65 or older or those with underlying health conditions. Supplies will be short, and allocating the medicine will be a challenge.
Operation Warp Speed's Logistics Chief Weighs In On Vaccine Progress
Gen. Gustave Perna says as soon as the FDA deems a vaccine safe and effective, his team is ready to coordinate deployment of tens of millions of doses as early as next month.
Pfizer Says Experimental COVID-19 Vaccine Is More Than 90% Effective
Pfizer's COVID-19 vaccine is the first to have data showing that it exceeded the minimum effectiveness threshold set by the Food and Drug Administration for emergency use.